Technology trained on millions of routine ECGs could fast-track high-risk patients for treatment ...
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new ...
A Novartis AG drug billed as a potential blockbuster failed to reduce the risk of heart attacks and strokes in a final-stage ...
Heart disease and kidney disease are closely linked, and kidney damage can remain silent for years. These simple blood, urine ...
Researchers analyzed 22 studies to better understand how different sources of trans fats affect cardiometabolic health — and ...
Cardiologists reveal eight everyday habits that may quietly harm your heart, from excessive salt and inactivity to poor sleep ...
Let’s be honest: if you’re waiting months for a heart test, two seconds for an answer sounds like magic. Yet researchers in ...
The shingles vaccine Shingrix was linked to 9% better cardiovascular health compared with an older shingles vaccine, ...
Heart disease can often present differently in men and women. Dr Bhojraj explains why he doesn't ask the same questions about ...
A shocking incident involved a 26-year-old man who suffered a heart attack without any apparent risk factors. Following his ...
Dr. Parasuram Krishnamoorthy sits down with News 9 to discuss heart valve disease and the treatment options that exist for it ...
NDTV Profit on MSN
Novartis drug fails key test for new heart disease approach
Amgen and Eli Lilly & Co. are testing their own drugs to lower Lp(a), though they're further behind in development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results